Clinical Trial: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Press/Media

Period28 Oct 2021

Media coverage

2

Media coverage

  • TitleClinical Trial: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
    Media name/outletHealth Daily Digest (Ht Media)
    Country/TerritoryIndia
    Date28/10/21
    PersonsAmy Tiersten
  • TitleClinical Trial: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date28/10/21
    PersonsAmy Tiersten